Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Aging and CSF hydroxylase cofactor

A Williams, J Ballenger, R Levine

    Neurology
    |November 1, 1980
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Myocardial abscess: an unusual complication of long-term hemodialysis line presence.

    Clinical nephrology·1999
    Same author

    "One-stop" surgery: implications for anesthesiologists of an expedited pediatric surgical process.

    Southern medical journal·1999
    Same author

    Calculating the global burden of disease: time for a strategic reappraisal?

    Health economics·1999
    Same author

    Aerosol route enhances the contamination of intact eggs and muscle of experimentally infected laying hens by Salmonella typhimurium DT104.

    FEMS microbiology letters·1999
    Same author

    Short gastric artery perforation after use of 'ecstasy'.

    Journal of the Royal Society of Medicine·1999
    Same author

    Meniscal movement. An in-vivo study using dynamic MRI.

    The Journal of bone and joint surgery. British volume·1999
    Same journal

    Factors Associated With Disability Improvement and Worsening Independent of Attacks in Patients With AQP4-IgG+ NMOSD and MOGAD: A Multicenter Cohort Study.

    Neurology·2026
    Same journal

    Cost-Effectiveness of Intracranial Aneurysm Screening: A Systematic Review.

    Neurology·2026
    Same journal

    Rare Eating Epilepsy: Co-Occurrence of Focal Cortical Dysplasia and Gray Matter Heterotopia.

    Neurology·2026
    Same journal

    Spatiotemporal Associations Between Cortical Microinfarcts and Cortical Superficial Siderosis in Cerebral Amyloid Angiopathy.

    Neurology·2026
    Same journal

    Blood-Brain Barrier Disruption Before Interhospital Transfer for Thrombectomy and Clinical Outcome.

    Neurology·2026
    Same journal

    At Death's Door: Cytosolic Dopamine in Patients With Parkinson Disease.

    Neurology·2026
    See all related articles

    Cerebrospinal fluid hydroxylase cofactor activity declines with age in healthy individuals. Parkinson

    Area of Science:

    • Neurochemistry
    • Neurology
    • Aging research

    Background:

    • Hydroxylase cofactors are crucial for neurotransmitter synthesis.
    • Aminergic neuron loss is implicated in aging and neurodegenerative diseases.

    Purpose of the Study:

    • To investigate age-related changes in cerebrospinal fluid (CSF) hydroxylase cofactor activity.
    • To compare cofactor levels in Parkinson disease patients versus healthy controls.

    Main Methods:

    • Measurement of hydroxylase cofactor activity in CSF samples.
    • Analysis of data stratified by age and neurological status (healthy vs. Parkinson disease).

    Main Results:

    • CSF hydroxylase cofactor levels decreased by approximately one-third over a 40-year age span in normal individuals.

    Related Experiment Videos

  • Parkinson disease patients generally exhibited lower cofactor levels than age-matched controls.
  • Younger Parkinson disease patients with similar disability showed higher CSF cofactor concentrations than older patients.
  • Conclusions:

    • Age-related decline in CSF hydroxylase cofactor activity may reflect aminergic neuron loss.
    • Reduced cofactor levels might be associated with Parkinson disease pathophysiology.
    • Disease progression or age may differentially impact cofactor levels in Parkinson disease.